No Data
Why Transmedics Plunged in December
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $125
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $90
Piper Sandler Sticks to Its Buy Rating for TransMedics Group (TMDX)
TCMD Stock Rises 20% in Three Months: Should You Buy, Hold or Sell?
ABAT, KULR and GME Among Trending Stocks in the Slow Holiday-shortened Week